Trials / Completed
CompletedNCT01162967
Clinical Trial For The Treatment Of Chronic Chagas Disease With Posaconazole And Benznidazole
PROTOCOL FOR PHASE II CLINICAL TRIAL, RANDOMIZED AND OPEN FOR ETIOLOGICAL TREATMENT OF CHRONIC CHAGAS DISEASE WITH POSACONAZOLE AND BENZNIDAZOLE
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 78 (actual)
- Sponsor
- Hospital Universitari Vall d'Hebron Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators propose the evaluation of posaconazole and benznidazole in humans for the treatment of Chagas disease chronical infection. Exploratory trial of posaconazole antiparasitic activity against Trypanosoma cruzi.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Benznidazole | Standard dosage |
| DRUG | Posaconazole |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2012-12-01
- Completion
- 2013-03-01
- First posted
- 2010-07-15
- Last updated
- 2013-09-10
Locations
3 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT01162967. Inclusion in this directory is not an endorsement.